Identifying factors that predict survival and neurological outcomes in patients treated with E-CPR.
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
This study looks at patients who received ECMO treatment after a cardiac arrest to see what factors can help predict their survival and brain recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT04198792 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have undergone extracorporeal membrane oxygenation (ECMO) treatment after cardiac arrest. It aims to identify predictors of good neurological outcomes by analyzing data from the Gothenburg ECPR cohort. The study will assess the effectiveness of pre-primed ECMO circuits and evaluate the current neurological prognostication guidelines for comatose patients. Additionally, long-term follow-up will be conducted to understand the neuropsychological outcomes and life satisfaction of ECPR survivors.
Who should consider this trial
Good fit: Ideal candidates for this study are patients treated with ECMO at Sahlgrenska University Hospital following cardiac arrest.
Not a fit: Patients who do not receive ECMO treatment or those with severe pre-existing neurological conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient selection for ECPR, enhancing survival rates and neurological outcomes for cardiac arrest patients.
How similar studies have performed: Other studies have shown success in refining patient selection criteria for ECMO, but this specific approach is novel in its focus on ECPR outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ECMO-treated patients. Exclusion Criteria: * None
Where this trial is running
Gothenburg
- Sahlgrenska Academy at Sahlgrenska University Hospital — Gothenburg, Sweden (Recruiting)
Study contacts
- Principal investigator: Bengt Redfors, MD, PhD — The Sahlgrenska Academy ar Sahlgrenska University Hospital, Gorhenburg, Sweden
- Study coordinator: Bengt Redfors, MD, PhD
- Email: bengt.redfors@vgregion.se
- Phone: +46768445402
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.